Industry news
Boston Scientific acquires Millipede Inc. and with it Iris Transcatheter Annuloplasty Ring System
Boston Scientific Corporation announced it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study. The acquisition will expand the Boston Scientific Structural Heart portfolio to include the IRIS Transcatheter Annuloplasty Ring System which is in development for the treatment of patients with severe mitral regurgitation who are not able to tolerate open-heart surgery.